AmplifyBio

AmplifyBio's Karen Elsass, Brandon Lewis, and Marcus Stepp delivered a well-attended presentation at the ACT Annual Meeting, focusing on advanced strategies and methods for safety testing of next-generation therapeutics. Their talk was highly insightful and received excellent feedback from colleagues. #amplifybio #toxicology #ACT2024

Accelerate your drug development with AmplifyBio’s flexible Plasmid Manufacturing. From R&D to cGMP-grade, we offer rapid turnaround, no minimum lot sizes, and a versatile platform for multiple plasmid types—all in a cGMP environment. Download the flyer here: https://bit.ly/3Of101F #PlasmidManufacturing #AmplifyBio #cGMP

We're having a great time at the American College of Toxicology (ACT) 2024 Annual Meeting! Stop by booth #309 to chat or join us Wednesday at noon for our "Tox Talk." Let's discuss how AmplifyBio can enhance your studies. #ACT2024 #amplifybio #americancollegeoftoxicology #ACTannualmeeting

Our CEO, J. Kelly Ganjei, will attend the J.P. Morgan Healthcare Conference 2025 in San Francisco. Schedule a meeting to learn more about AmplifyBio and how we're enhancing the safety and accelerating the manufacture of advanced therapies. Request a meeting: https://bit.ly/4eDiJdT #amplifybio #advancedtherapies #jpmorgan2025

Join AmplifyBio on a journey of scalable innovation. Our flexible, phased approach to facility expansion allows us to adapt and grow alongside your needs. With an open footprint and modular design, we ensure that your input helps shape the future of our space, offering a tailored solution to meet the demands of tomorrow’s therapies. Learn more at: https://lnkd.in/g2Nz_mCr #CGTmanufacturing #coldchain #AmplifyBio

AmplifyBio scientists and technicians were proud to present and learn from their peers at the annual AALAS conference last week. AmplifyBio shared the following insights: "Successful Execution of Intravenous Vascular Access Button Dosing on BALB/c Mice with Submandibular Blood Collection", "Monitoring Automatic Watering for Vivarium Animals", "Reducing Adeno-associated Virus Seroconversion in Non-Human Primate Colonies" through posters. They also hosted a talk on "The Nanopig Experience."

Enhance your research with AmplifyBio’s state-of-the-art surgical facilities and cutting-edge imaging technology. Our mobile MRI unit, integrated with ClearPoint Neuro’s software, ensures precise and safe procedures for even the most complex studies. Learn more at: https://lnkd.in/gBKjwY9n #safetypharmacology #preclinicalsafety #preclinical #AmplifyBio

Discover the latest insights into immunological testing for gene therapy success! Learn how specialized immunological assays support the translatability and safety of gene therapies by examining drug potency, immune responses, and potential risks. Read here: https://bit.ly/3UGmPLv #GeneTherapy #Immunology #AdvancedTherapies #AmplifyBio

Join AmplifyBio at the ACT Annual Meeting for a "Tox Talk" on advanced strategies and methods in safety testing for next-generation therapeutics. Don’t miss this opportunity to learn and connect! #ACT #AmplifyBio #Toxicology

AmplifyBio is driving growth in partnership with Vitrian. Vitrian, the leading end-to-end provider of investment capital and capacity-building services for biomanufacturing, announced today that it closed a $50 million investment, with the ability to scale to $65 million, into AmplifyBio’s Manufacturing Enablement Center (AMEC) in New Albany, Ohio https://lnkd.in/gJ-APCHF